COSMO Insight Report

“Patient Insight Report: Women’s Cancer”


The anticancer therapy market has increased threefold in the last ten years. Once considered an incurable disease, the five-year survival rate is improving every year and cancer today is increasingly becoming a disease that one “lives with.”

An increase in cancer treatment options has prompted new medical practices. Informed consent sees patients agree to treatment options only after receiving explanations from their physicians, while shared decision-making has physicians and patients confirm evidential information and select treatment methods together. Healthcare today is shifting from treatment that physicians one-sidedly offer, to one that patients proactively learn about and choose.

This report examines women’s cancer (gynecological and breast cancer) patients’ attitudes and behaviors when selecting treatment, with a focus on patients of the three main women’s cancers. It then sets out to determine how the volume and content of media coverage influence the patient’s decision-making on treatment, as well as the influence of activities by patient group and information shared by individuals.


Research Overview:

1. Women’s cancer patients’ attitudes toward treatment 

To understand gynecological cancer patients’ attitudes and behavior when selecting treatment

Period:  March 11, 2020 – March 16, 2020

Method:  Online survey

Male and female nationwide, aged 20-68, patients of ten cancer types

Sample size:
Total of 300 respondents (patients of all ten cancer types), of which 90 respondents are patients of the three primary gynecological cancer types or breast cancer (ovarian cancer patients: 30, cervical and endometrial cancer patients: 30, breast cancer patients: 30)

Research company: Rakuten Insight, Inc.


2. Empowerment by women’s cancer patient groups

To understand the influence of patient groups, patient support groups, and individuals on social media

Research criteria:
A. Patient groups’ number of members, partner companies and organizations, experience of representatives, volume of media coverage, social media activity etc.
Period: January 1, 2017 – December 31, 2019

B. Patient, former patient, patient families, and healthcare providers’ Twitter activity, including number of followers, tweets, and retweets and the content of tweets
Period: January 1, 2019 – December 31, 2019


3. Media coverage trends for women’s cancer

A. Analysis of coverage on women’s cancer
B. Analysis of coverage on companies in women’s cancer area

Analysis criteria:
Number, trends, and tone of articles on women’s cancer, diseases, and related companies by the five national papers (searched via Nikkei Telecom)

Period:  January 1, 2019 – December 31, 2019

Price list:

Language types of report, Option Fee Fee (incl. tax)
Japanese report (global license) 300,000JPY 330,000JPY
English report (global license) 300,000JPY 330,000JPY
English & Japanese report (global license) 500,000JPY 550,000JPY
□ Option: Presentation 100,000JPY 110,000JPY

*Upon purchase, you will receive the report in PDF format.

**Use restrictions: circulation of the report is restricted to your internal use only, including international offices.

岩下裕司COSMO Insight Report “Patient Insight Report: Women’s Cancer”